Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

UNCY Unicycive Therapeutics Inc

0,64

-0,0137 (-2,10%)

22 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Unicycive Therapeutics (NASDAQ:UNCY)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Unicycive Therapeutics Charts.

Unicycive Therapeutics (NASDAQ:UNCY)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Unicycive Therapeutics Charts.

News Unicycive Therapeutics Inc

Form 8-K - Current report
Dienstag 7 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Donnerstag 21 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Freitag 15 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Freitag 15 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Unicycive Therapeutics Delivers Multiple Poster Presentations Highlighting Development Progress on Oxylanthanum Carbonate (OLC) and UNI-494 at the American Society of Nephrology (ASN) Kidney Week 2024
Montag 28 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Unicycive Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on October 17, 2024
Mittwoch 16 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Unicycive Therapeutics Announces Late-Breaker Poster Presentation on Oxylanthanum Carbonate (OLC) at the American Society of Nephrology (ASN) Kidney Week 2024
Montag 14 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Freitag 11 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy Volunteers
Mittwoch 9 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Unicycive Therapeutics Inc News-Artikel

Health Care Select Sector

BNP Paribas (QX)

Euro vs US Dollar

Euro vs Sterling

Deutsche Telekom (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen